ROSA GOMEZ: Open Payments
NPI 1891573176 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 29 payments from 14 companies in 2025. Trend: 2023 $17 · 2024 $549 · 2025 $1,157
Food & beverage: $1,157
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $430 |
| Novo Nordisk Inc | 2 | $215 |
| Edwards Lifesciences Corporation | 1 | $133 |
| Esperion Therapeutics, Inc. | 2 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $49 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Stryker Corporation | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| W. L. Gore & Associates, Inc. | 1 | $27 |
Products named: REPATHA, Wegovy, NEXLETOL, LEQVIO, LifeVest, VERQUVO, ARTIX MT, OPSUMIT.
Industry payments across AZ — which companies pay providers there.
